Cencora directors agreed to an $111 million settlement on August 18, 2025, to resolve litigation alleging opioid mismanagement. The settlement brings to a close a lawsuit from pension funds that argued Cencora’s leadership ignored red flags about improper opioid distribution practices for years.
The litigation claimed that the directors prioritized profit over preventing the diversion of controlled substances. This settlement addresses a specific legal challenge against the company's leadership.
This resolution helps to mitigate ongoing legal and reputational risks associated with the opioid crisis for Cencora's board members. The settlement amount is a concrete figure related to the company's past legal challenges.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.